US Patent Issued to Fresenius Medical Care Holdings on May 19 for "Peptidoglycan (PGN) aptamers and associated methods" (Tennessee Inventor)

ALEXANDRIA, Va., May 19 -- United States Patent no. 12,631,636, issued on May 19, was assigned to Fresenius Medical Care Holdings Inc. (Waltham, Mass.).

"Peptidoglycan (PGN) aptamers and associated methods" was invented by Tao Jiang (Knoxville, Tenn.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Described are a number of aptamers that are specific to bind with peptidoglycan ("PGN") with specificity over counter-targets lipopolysaccharides ("LPS") and lipoteichoic acid ("LTA"), and associated methods."

The patent was filed on Feb. 2, 2022, under Application No. 17/591,533.

*For further information, including images, charts and tables, please visit: http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2...